Vaccine Potpourri

Co-Moderator(s)

• 

  Nkuchia M'ikanatha, DrPH, MPH

  Epidemiologist
  University of Pennsylvania School of Medicine
  Perelman School of Medicine, University of Pennsylvania
  Hummelstown, United States
• 

  Morgan Marks, PhD (he/him/his)

  Senior Director
  Infectious Disease Epidemiology, Moderna Therapeutics Inc.
  Cambridge, United States

Presentations:

• 5:15 PM – 5:30 PM ADT

  The Contribution of Immunization Information System Data to Claims-Based Capture of Vaccines Used to Prevent Mpox and Implications for Claims-Based Mpox Surveillance
  

  Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
• 5:30 PM – 5:45 PM ADT

  High-Dose Influenza Vaccine Receipt: Geographic Variation in Racial Health Disparities
  

  Presenting Author: Joe B.B Silva, ScM (he/him/his) – Brown University School of Public Health
• 5:45 PM – 6:00 PM ADT

  Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. The Vaccine Safety Datalink
  

  Presenting Author: Ousseny Zerbo, PhD – Kaiser Permanente Northern California, Vaccine Study Center
• 6:00 PM – 6:15 PM ADT

  Comparing Vaccination Timeliness among U.S. Children in the 2019 and 2021 National Immunization Survey-Child
  

  Presenting Author: Sophia R. Newcomer, PhD, MPH (she/her/hers) – University of Montana Center for Population Health Research
• 6:15 PM – 6:30 PM ADT

  Statins may modulate the effectiveness of the flu vaccine according to the type of respiratory outcome: Results from the Statin Treatment OPtions during vaccination against inFLUenza (STOPFlu) study
  

  Presenting Author: William Henley – University of Exeter
• 6:30 PM – 6:45 PM ADT

  Assessment of Neurological and Immunological Adverse Events Following Childhood Pneumococcal Vaccination: a Population-Based Self-Controlled Risk Interval Analysis
  

  Presenting Author: Ju Hwan Kim, PharmD, PhD (he/him/his) – School of Pharmacy, Sungkyunkwan University, South Korea